Literature DB >> 16612703

Intrapartum transfer from a birth centre to a hospital - reasons, procedures, and consequences.

M David1, G Berg, I Werth, J Pachaly, A Mansfeld, H Kentenich.   

Abstract

BACKGROUND: Investigation of the reasons for the transfer of women from a birth centre to a hospital in the course of childbirth as well as modalities and effects. PATIENTS AND
METHOD: In the prospective investigation from September 1, 1999 to August 31, 2001, information was collected for all women in Berlin and Bavaria transferred intrapartum from a birth centre to a hospital concerning the reason for the transfer, stage of delivery at the start of transfer, details of the transport, accompaniment, state of mother and medical diagnosis on arrival at the hospital, further progress of delivery, and the condition of the baby postnatum. Comparison groups were formed by all birth centre deliveries in Berlin and Bavaria 1999/2000 (n = 3060) and hospital deliveries in Berlin and Bavaria 1998/1999 (selected data, n = 89 696 births).
RESULTS: Three hundred and sixty transfer cases could be evaluated, and a majority of these were nulliparous. The most frequent reasons for transfer were prior premature rupture of membranes and failure to progress in labor. Fifty-seven percentages of the women who were transferred subsequently delivered spontaneously, with an episiotomy rate of approximately 30%. 1-min Apgar value < or = 7 were frequently in nulliparous and multiparous patients in the transfer group than in the comparison groups, as were 5-min Apgar values < or = 7 and pH < 7.10 in arterial cord blood in particular for nulliparous in the transfer group. Hospitalisation of neonates born to the transfer group and in particular the nulliparous was significantly more common.
CONCLUSIONS: Women delivering in a birth centre represent in general a low-risk group as a result of careful preselection by the centres. However, some neonatal data and the high rate of operative deliveries (cesarean section, forceps, and vaginal extraction) indicate that the intrapartum-transferred women, in particular when nulliparous, represent than a special high-risk group.

Entities:  

Mesh:

Year:  2006        PMID: 16612703     DOI: 10.1080/00016340600593174

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  5 in total

1.  Duration and urgency of transfer in births planned at home and in freestanding midwifery units in England: secondary analysis of the birthplace national prospective cohort study.

Authors:  Rachel E Rowe; John Townend; Peter Brocklehurst; Marian Knight; Alison Macfarlane; Christine McCourt; Mary Newburn; Maggie Redshaw; Jane Sandall; Louise Silverton; Jennifer Hollowell
Journal:  BMC Pregnancy Childbirth       Date:  2013-12-05       Impact factor: 3.007

2.  Defining and describing birth centres in the Netherlands - a component study of the Dutch Birth Centre Study.

Authors:  M A A Hermus; I C Boesveld; M Hitzert; A Franx; J P de Graaf; E A P Steegers; T A Wiegers; K M van der Pal-de Bruin
Journal:  BMC Pregnancy Childbirth       Date:  2017-07-03       Impact factor: 3.007

3.  Model of care and chance of spontaneous vaginal birth: a prospective, multicenter matched-pair analysis from North Rhine-Westphalia.

Authors:  Sophia L Tietjen; Marie-Therese Schmitz; Andrea Heep; Andreas Kocks; Lydia Gerzen; Matthias Schmid; Ulrich Gembruch; Waltraut M Merz
Journal:  BMC Pregnancy Childbirth       Date:  2021-12-30       Impact factor: 3.007

4.  Risk assessment and decision making about in-labour transfer from rural maternity care: a social judgment and signal detection analysis.

Authors:  Helen Cheyne; Len Dalgleish; Janet Tucker; Fiona Kane; Ashalatha Shetty; Sarah McLeod; Catherine Niven
Journal:  BMC Med Inform Decis Mak       Date:  2012-10-31       Impact factor: 2.796

5.  Towards a better understanding of risk selection in maternal and newborn care: A systematic scoping review.

Authors:  Bahareh Goodarzi; Annika Walker; Lianne Holten; Linda Schoonmade; Pim Teunissen; François Schellevis; Ank de Jonge
Journal:  PLoS One       Date:  2020-06-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.